These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31097696)

  • 1. Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screening.
    Picco G; Chen ED; Alonso LG; Behan FM; Gonçalves E; Bignell G; Matchan A; Fu B; Banerjee R; Anderson E; Butler A; Benes CH; McDermott U; Dow D; Iorio F; Stronach E; Yang F; Yusa K; Saez-Rodriguez J; Garnett MJ
    Nat Commun; 2019 May; 10(1):2198. PubMed ID: 31097696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene fusions in tumourigenesis with particular reference to ovarian cancer.
    Zhou Y; El-Bahrawy M
    J Med Genet; 2021 Dec; 58(12):789-795. PubMed ID: 34462289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hacking the Cancer Genome: Profiling Therapeutically Actionable Long Non-coding RNAs Using CRISPR-Cas9 Screening.
    Esposito R; Bosch N; Lanzós A; Polidori T; Pulido-Quetglas C; Johnson R
    Cancer Cell; 2019 Apr; 35(4):545-557. PubMed ID: 30827888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partner independent fusion gene detection by multiplexed CRISPR-Cas9 enrichment and long read nanopore sequencing.
    Stangl C; de Blank S; Renkens I; Westera L; Verbeek T; Valle-Inclan JE; González RC; Henssen AG; van Roosmalen MJ; Stam RW; Voest EE; Kloosterman WP; van Haaften G; Monroe GR
    Nat Commun; 2020 Jun; 11(1):2861. PubMed ID: 32504042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agreement between two large pan-cancer CRISPR-Cas9 gene dependency data sets.
    Dempster JM; Pacini C; Pantel S; Behan FM; Green T; Krill-Burger J; Beaver CM; Younger ST; Zhivich V; Najgebauer H; Allen F; Gonçalves E; Shepherd R; Doench JG; Yusa K; Vazquez F; Parts L; Boehm JS; Golub TR; Hahn WC; Root DE; Garnett MJ; Tsherniak A; Iorio F
    Nat Commun; 2019 Dec; 10(1):5817. PubMed ID: 31862961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Landscape analysis of adjacent gene rearrangements reveals BCL2L14-ETV6 gene fusions in more aggressive triple-negative breast cancer.
    Lee S; Hu Y; Loo SK; Tan Y; Bhargava R; Lewis MT; Wang XS
    Proc Natl Acad Sci U S A; 2020 May; 117(18):9912-9921. PubMed ID: 32321829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
    Gerhards NM; Rottenberg S
    Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Landscape of gene fusions in epithelial cancers: seq and ye shall find.
    Kumar-Sinha C; Kalyana-Sundaram S; Chinnaiyan AM
    Genome Med; 2015 Dec; 7():129. PubMed ID: 26684754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent and pathological gene fusions in breast cancer: current advances in genomic discovery and clinical implications.
    Veeraraghavan J; Ma J; Hu Y; Wang XS
    Breast Cancer Res Treat; 2016 Jul; 158(2):219-32. PubMed ID: 27372070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of recurrent, rare, and novel gene fusions in patients with acute leukemia using next-generation sequencing approaches.
    Kim B; Kim E; Lee ST; Cheong JW; Lyu CJ; Min YH; Choi JR
    Hematol Oncol; 2020 Feb; 38(1):82-88. PubMed ID: 31875988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. InFusion: Advancing Discovery of Fusion Genes and Chimeric Transcripts from Deep RNA-Sequencing Data.
    Okonechnikov K; Imai-Matsushima A; Paul L; Seitz A; Meyer TF; Garcia-Alcalde F
    PLoS One; 2016; 11(12):e0167417. PubMed ID: 27907167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR screen in mechanism and target discovery for cancer immunotherapy.
    Liu D; Zhao X; Tang A; Xu X; Liu S; Zha L; Ma W; Zheng J; Shi M
    Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188378. PubMed ID: 32413572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.
    Gao Q; Liang WW; Foltz SM; Mutharasu G; Jayasinghe RG; Cao S; Liao WW; Reynolds SM; Wyczalkowski MA; Yao L; Yu L; Sun SQ; ; ; Chen K; Lazar AJ; Fields RC; Wendl MC; Van Tine BA; Vij R; Chen F; Nykter M; Shmulevich I; Ding L
    Cell Rep; 2018 Apr; 23(1):227-238.e3. PubMed ID: 29617662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation Sequencing.
    Beadling C; Wald AI; Warrick A; Neff TL; Zhong S; Nikiforov YE; Corless CL; Nikiforova MN
    J Mol Diagn; 2016 Mar; 18(2):165-75. PubMed ID: 26747586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Project Score database: a resource for investigating cancer cell dependencies and prioritizing therapeutic targets.
    Dwane L; Behan FM; Gonçalves E; Lightfoot H; Yang W; van der Meer D; Shepherd R; Pignatelli M; Iorio F; Garnett MJ
    Nucleic Acids Res; 2021 Jan; 49(D1):D1365-D1372. PubMed ID: 33068406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Fusions Create Partner and Collateral Dependencies Essential to Cancer Cell Survival.
    Gillani R; Seong BKA; Crowdis J; Conway JR; Dharia NV; Alimohamed S; Haas BJ; Han K; Park J; Dietlein F; He MX; Imamovic A; Ma C; Bassik MC; Boehm JS; Vazquez F; Gusev A; Liu D; Janeway KA; McFarland JM; Stegmaier K; Van Allen EM
    Cancer Res; 2021 Aug; 81(15):3971-3984. PubMed ID: 34099491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncovering Clinically Relevant Gene Fusions with Integrated Genomic and Transcriptomic Profiling of Metastatic Cancers.
    Tsang ES; Grisdale CJ; Pleasance E; Topham JT; Mungall K; Reisle C; Choo C; Carreira M; Bowlby R; Karasinska JM; MacMillan D; Williamson LM; Chuah E; Moore RA; Mungall AJ; Zhao Y; Tessier-Cloutier B; Ng T; Sun S; Lim HJ; Schaeffer DF; Renouf DJ; Yip S; Laskin J; Marra MA; Jones SJM; Loree JM
    Clin Cancer Res; 2021 Jan; 27(2):522-531. PubMed ID: 33148671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma.
    Guo T; Gaykalova DA; Considine M; Wheelan S; Pallavajjala A; Bishop JA; Westra WH; Ideker T; Koch WM; Khan Z; Fertig EJ; Califano JA
    Int J Cancer; 2016 Jul; 139(2):373-82. PubMed ID: 26949921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The landscape of long noncoding RNA-involved and tumor-specific fusions across various cancers.
    Guo M; Xiao ZD; Dai Z; Zhu L; Lei H; Diao LT; Xiong Y
    Nucleic Acids Res; 2020 Dec; 48(22):12618-12631. PubMed ID: 33275145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RWCFusion: identifying phenotype-specific cancer driver gene fusions based on fusion pair random walk scoring method.
    Zhao J; Li X; Yao Q; Li M; Zhang J; Ai B; Liu W; Wang Q; Feng C; Liu Y; Bai X; Song C; Li S; Li E; Xu L; Li C
    Oncotarget; 2016 Sep; 7(38):61054-61068. PubMed ID: 27506935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.